u/surveytiger

Reddit r/smallstreetbets
· tracked since Jan 2026
Calls
1
Win Rate
100.0%
return
+31.5%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 100% Long 1 Short 0
Win Rate
7d 0%
30d 0%
90d 0%
Average Return +31.5% Long Return +31.5% Short Return -
Average Return
7d -9.3%
30d -1.5%
90d -1.3%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 08
$34.44
+31.5%
Axogen's Avance FDA approval may improve insurance reimbursement.
The author argues Axogen's Avance nerve graft received FDA approval last month. They expect insurers to treat an FDA-approved product more favorably for reimbursement. This reimbursement shift could benefit Axogen this year.
MedTech
Showing 1 of 1 calls · sorted by mentions

u/surveytiger has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: AXGN.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology